Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Wits Clinical Research , Wits Health Consortium (PTY) Ltd /ID# 222669, Johannesburg

Thompson Cancer Survival Ctr /ID# 225802, Knoxville

Inje University Busan Paik Hospital /ID# 224043, Busan

University of Texas MD Anderson Cancer Center /ID# 221652, Houston

Stony Brook University Hospital /ID# 222653, Stony Brook

UC Health - Cincinnati /ID# 224079, Cincinnati

Alberts Cellular Therapy /ID# 222667, Pretoria